Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer
NCT04201990
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
Camrelizumab and Apatinib
Sponsor
ShiYue Li